🚀 Many thanks to Sciences & Avenir for highlighting the innovative technology developed by Cardiawave in their article “Ultrasound to Heal the Heart” published at the end of December!
We are pleased that our work is featured in this prestigious magazine and thank you for your support.
🌐 Cardiawave is developing a non-invasive ultrasound therapy device to treat patients with severe RAC (Calcified Aortic Narrowing), for which there is no solution today. The article in Sciences et Avenir highlights the promising results of Cardiawave’s clinical feasibility studies (“Valvosoft® FIM study”), which demonstrate an improvement in cardiac function and quality of life in treated patients. These results were published last November in the prestigious British scientific journal The lancet 💡
🔍 Read the article here: https://www.sciencesetavenir.fr/sante/coeur-et-cardio/des-ultrasons-pour-soigner-le-coeur_175895
@Emmanuel Messas @Mickael Tanter @Mathieu Pernot @Olivier Pierron
#HEGP, @AP-HP, Public Support – Paris Hospitals, @Physics for Medicine Paris, #Langevin Institute, @CNRS – National Center for Scientific Research, @ESPCI Paris – PSL, @Inserm @RHU STOP AS
@sciences-et-avenir #FocusedUltrasound #AorticStenosis #RAC #Medtech #FrenchCare #Health20 #NIUT #thelancet
Cardiawave highlighted by Sciences et Avenir! – Cardiawave
Related Posts
10 new members of the French Health Association in March
Find out who the ten companies are joining French Health Association in March 2024: Cahouet develops, produces and sells equipment for the use of pressurized medical gases. They have 80…
Epsidy, the cardiovascular health startup, has ISO certification
The young start-up with BPI’s Deeptech label has just received its ISO 13485 certification to continue its strong development and commercialization of very innovative medical devices for cardiac imaging. This…